Milestone for gene-edited therapy for sickle cell disease
Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics have announced that the European Medicines Agency (EMA) has…
January 26, 2023 - 3 minutes
Vertex Pharmaceuticals
Opportunities and challenges for cell and gene therapy investments
Companies in the cell and gene therapy space are struggling to raise investments amid adverse…
October 20, 2022 - 9 minutes
How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
November 22, 2021 - 9 minutes
CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders
CRISPR Therapeutics and its US partner Vertex Pharmaceuticals have released the first clinical results for…
November 19, 2019 - 3 minutes
CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
June 7, 2019 - 2 minutes
Vertex Partners Oxford Genome Analysis Firm To Develop New Personalized Therapies
Genomics, a company using machine learning to analyze genetic data, is partnering with precision medicine…
August 31, 2018 - 2 minutes
CRISPR Therapeutics Plans First CRISPR/Cas9 Clinical Trial in Europe for 2018
CRISPR Therapeutics and Vertex Pharmaceuticals are taking action to start a first clinical trial with…
December 13, 2017 - 3 minutes
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
Galapagos has announced to kick off a Phase I trial with its novel Cystic Fibrosis…
March 23, 2017 - 2 minutes
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
After Galapagos and AbbVie expanded their collaboration on cystic fibrosis, Galapagos now announces the start…
February 2, 2017 - 2 minutes
Merck expands its Oncology Pipeline beyond Checkpoint Inhibitors
Merck is diversifying its oncology portfolio with four new programs licensed from Vertex Pharmaceuticals, including…
January 11, 2017 - 2 minutes
French Microbiome Therapy boosted by compound from major US Biotech
Enterome, a leader in the European microbiome field, has struck a deal with US' Vertex…
April 19, 2016 - 3 minutes
Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal
CRIPSR's hype is not going down yet. CRIPSR/Cas9 or Cpf1 is a revolutionising gene editing…
October 26, 2015 - 2 minutes
